As Pharmacy Technician Day approaches, the CEO of the Pharmacy Technician Certification Board argues that real recognition means career ladders, consistent scope regulations, and investment in certification.
|Articles|June 19, 2017
- June 2017 Women's Health
- Volume 83
- Issue 6
Pet Peeves (June 2017)
Read about rushed prescriptions, blissful ignorance, and more pet peeves.
Advertisement
GAME DAY RUSHES
Patients who ask us to prioritize their prescriptions because they have to hurry home to watch a sports game.
EVERYTHING BUT THAT
When patients ask us to refill all of their prescriptions without specifying which ones they need, but then angrily return a few that they claim they didn’t request.
BLISSFUL IGNORANCE
When patients ask me for advice only to ignore me when I tell them something they don’t want to hear.
OUR LITTLE SECRET
Patients who ask me to do things that would get me fired, insisting that it would be “just this once.”
Articles in this issue
over 9 years ago
Case Studies (June 2017)over 9 years ago
Can You Read These Rxs? (June 2017)over 9 years ago
Generic Product News (June 2017)over 9 years ago
Naloxone Nasal Spray More Generics on the Horizon?over 9 years ago
Medication Therapy Management and Health Care Reformover 9 years ago
Mental Illness Linked to Heightened Cardiovascular Disease Riskover 9 years ago
Poor Diet Linked to Premenopausal Breast Cancer RiskAdvertisement
Related to this article
William J. Peppard, PharmD, explains how emerging suzetrigine findings after knee arthroplasty connect opioid stewardship with functional recovery and the pharmacist’s role in ensuring treatment access.
Tor Härnqvist, MD, discusses immune testing after invasive pneumococcal disease, serotype-informed vaccine selection, and pharmacists' role in supporting patients on immunoglobulin therapy.
In adults with type 2 diabetes at high cardiovascular (CV) risk, the oral GLP-1 RA also improved HbA1C and weight, with less hypoglycemia but more GI events.
In an interview with Pharmacy Times, LINKER-SMM1 study investigator Paula Rodríguez-Otero, MD, PhD, a hematologist at Clínica Universidad de Navarra in Pamplona, Spain, explains how researchers selected high-risk patients and how she weighs infections against the potential to prevent progression to active disease.
BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1C by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Butter, Beef Tallow, and LDL: Where Dietary Guidelines Diverge
2
Why Patients Fear Statins Will Affect Their Memory
3
Suzetrigine After Knee Replacement: Are Fewer Opioid Prescriptions Enough?
4
Orforglipron Shows CV Safety vs Insulin Glargine in ACHIEVE-4
5